October 27, 2010

The Food and Drug Administration has approved a new usage for a blood cancer drug,...

October 25, 2010

An investigative vaccine made by Novartis appears to offer good protection against meningococcal disease in...

October 21, 2010

Drug maker Hospira has launched a generic treatment for bacterial infections, Hospira said Thursday....

October 21, 2010

Sandoz has launched a generic antibiotic drug, the generics division of Swiss drug maker Novartis...

October 17, 2010

The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market...

October 10, 2010

Humanity has come a long way since the days when people thought sickness came from...

October 4, 2010

Eye care company Alcon has appointed a new executive....

October 4, 2010

Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...

September 27, 2010

The market for hypertension drugs will drop by $3 billion by the end of the...

September 26, 2010

Biosimilars, biogenerics, follow-on biologics—whatever the designation one prefers for knockoffs of biotech drugs—they will soon...

September 23, 2010

Drug maker Warner Chilcott will buy the U.S. rights to a treatment for overactive bladder...

September 21, 2010

The Food and Drug Administration has approved a drug for reducing relapses in patients with...

September 21, 2010

Swiss drug maker Novartis said its investigational drug is the first to show promise in...

August 31, 2010

The charitable arm of the National Association of Chain Drug Stores received contributions from several...

August 29, 2010

Jeffrey Bailey has been appointed as King Pharmaceuticals' chief commercial officer, leading all sales, marketing,...

August 26, 2010

The Food and Drug Administration has approved a single-pill combination of two drugs made by...

August 25, 2010

Novartis on Thursday announced that it has completed its purchase of Alcon stock from Nestle,...

August 16, 2010

The global market for vaccines grew to more than $20 billion last year, according to...

July 22, 2010

The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected...

July 15, 2010

Sales and profits grew significantly for Swiss drug maker Novartis, with significant growth across divisions,...

July 14, 2010

Biotech giant Amgen has appointed a former Novartis executive to its board, Amgen said Thursday....

July 13, 2010

Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said....

July 11, 2010

Sandoz has launched a generic drug for treating migraine headaches, the generics arm of Swiss...

July 11, 2010

A cancer drug made by Bristol-Myers Squibb and Otsuka Pharmaceutical has received priority review from...